Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

PLX3618 is a monovalent direct degrader of bromodomain-containing protein 4 (BRD4).1 It binds to both bromodomain 1 (BD1) and BD2 of BRD4 and mediates its degradation via recruitment of the E3 ubiquitin ligase DDB1- and CUL4-associated factor 11 (DCAF11) with a half-maximal degradation concentration (DC50) value of 12.2 nM. PLX3618 inhibits the proliferation of a variety of hematopoietic cancer cells and induces apoptosis in MV4-11 acute myeloid leukemia (AML) cells. It induces tumor regression and intratumoral BRD4 degradation in an MV4-11 mouse xenograft model when administered at a dose of 5 mg/kg.
WARNING This product is not for human or veterinary use.
1. Discovery of monovalent direct degraders of BRD4 that act via the recruitment of DCAF11. Mol. Cancer Ther. 23(10), 1446-1458 (2024).